维普中文期刊产品整合服务
9篇 您的检索式:作者名="Faiferman I"
    题名 作者 年代 出处 被引量
1A study to evaluatesafety and efficacy of mepolizumab in patients with moderate per- sistent asthma显示文摘Flood-Page P Swenson C Faiferman I 2007Am J Respir Crit Care Med2007,176,:1
2A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma显示文摘Flood-Page P Swenson C Faiferman I 2007Am J Respir Crit Care Med2007,176,:1
3A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma 显示文摘Flood-Page P Swenson C Faiferman I 2007Am J Respir Crit Care Med2007,176,11:1
4A study to evaluate safety and efficacy of mepolizumab in patients with moderate pesisitent asthma显示文摘Flood-Page P Swenson C Faiferman I 2007Am J Respir Crit Care Med2007,176,11:1
5A cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early and late phase bronchoconstriction and airway hyperesponsiveness in asthmatic subjects 显示文摘HAMIHON A FAIFERMAN I STOPER P 1998Allergy Clin Lmmunol1998,102,:1
6Avidity of anti-DNA an- tibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus, association of high avidity antinative DNA antibody with glomerulonephritis显示文摘Winfield J B Faiferman I Koffler D 2007J Clin Invest2007,59,1:1
7A study to evaluate safety and efficocy of mepolizumab in patients with moderate persistent asthma显示文摘Flood-Page P Swenson C Faiferman I 2007Am J Respir Crit Care Med2007,176,11:1
8Pranlukast,a cysteinyl leukotriene receptor antagonist, attenuates al-lergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects显示文摘Hamilton A Faiferman I Stober P 1998J Allergy Clin Immunol1998,102,2:1
9显示文摘Hamilton A Faiferman I Stober P 1998J Allergy Clin Immunol1998,102,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费